Zdrowie i gospodarka · 30/05/2003
FDA to Host Public Meeting on Minimizing Medication Errors through Evaluation of Proprietary Drug Names
The FDA, in collaboration with PhRMA and ISMP, is hosting a public meeting to discuss methods for evaluating proprietary drug names to reduce medication errors, with a focus on potential changes to the drug approval process.
Source: Federal Register — Food and Drug AdministrationOpen original release →